- Home
- Publications
- Publication Search
- Publication Details
Title
Gene Therapy for ALS—A Perspective
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 18, Pages 4388
Publisher
MDPI AG
Online
2019-09-09
DOI
10.3390/ijms20184388
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- C9orf72 deficiency promotes motor deficits of a C9ALS/FTD mouse model in a dose-dependent manner
- (2019) Qiang Shao et al. Acta Neuropathologica Communications
- Artificial MicroRNAs Targeting C9orf72 Can Reduce Accumulation of Intra-nuclear Transcripts in ALS and FTD Patients
- (2019) Raygene Martier et al. Molecular Therapy-Nucleic Acids
- Genetics of amyotrophic lateral sclerosis: A review
- (2019) Stéphane Mathis et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy
- (2019) Raygene Martier et al. Molecular Therapy-Nucleic Acids
- Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models
- (2018) Alex McCampbell et al. JOURNAL OF CLINICAL INVESTIGATION
- Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
- (2018) Eugenio Mercuri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oligonucleotide therapeutics in neurodegenerative diseases
- (2018) Daniel R. Scoles et al. RNA Biology
- Translating SOD1 Gene Silencing toward the Clinic: A Highly Efficacious, Off-Target-free, and Biomarker-Supported Strategy for fALS
- (2018) Tommaso Iannitti et al. Molecular Therapy-Nucleic Acids
- Emerging Issues in AAV-Mediated In Vivo Gene Therapy
- (2018) Pasqualina Colella et al. Molecular Therapy-Methods & Clinical Development
- Gene therapy for neurological disorders: progress and prospects
- (2018) Benjamin E. Deverman et al. NATURE REVIEWS DRUG DISCOVERY
- C9orf72-mediated ALS and FTD: multiple pathways to disease
- (2018) Rubika Balendra et al. Nature Reviews Neurology
- Non-viral Delivery of Nucleic Acids: Insight Into Mechanisms of Overcoming Intracellular Barriers
- (2018) Mikhail Durymanov et al. Frontiers in Pharmacology
- Safe and effective superoxide dismutase 1 silencing using artificial microRNA in macaques
- (2018) Florie Borel et al. Science Translational Medicine
- Genetic manipulation of specific neural circuits by use of a viral vector system
- (2017) Kenta Kobayashi et al. JOURNAL OF NEURAL TRANSMISSION
- A New AAV10-U7-Mediated Gene Therapy Prolongs Survival and Restores Function in an ALS Mouse Model
- (2017) Maria Grazia Biferi et al. MOLECULAR THERAPY
- Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases
- (2017) Kathleen M. Schoch et al. NEURON
- Viral vectors for therapy of neurologic diseases
- (2017) Sourav R. Choudhury et al. NEUROPHARMACOLOGY
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Amyotrophic Lateral Sclerosis
- (2017) Robert H. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
- (2017) Richard S. Finkel et al. NEW ENGLAND JOURNAL OF MEDICINE
- ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?
- (2017) Dmitry Petrov et al. Frontiers in Aging Neuroscience
- Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis
- (2017) Andrew P. Tosolini et al. Frontiers in Molecular Neuroscience
- Additive amelioration of ALS by co-targeting independent pathogenic mechanisms
- (2017) Ashley E. Frakes et al. Annals of Clinical and Translational Neurology
- In vivo genome editing improves motor function and extends survival in a mouse model of ALS
- (2017) Thomas Gaj et al. Science Advances
- Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model
- (2016) Lorelei Stoica et al. ANNALS OF NEUROLOGY
- The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy
- (2016) Christopher P Webster et al. EMBO JOURNAL
- Therapeutic rAAVrh10 MediatedSOD1Silencing in AdultSOD1G93AMice and Nonhuman Primates
- (2016) Florie Borel et al. HUMAN GENE THERAPY
- Intrathecal Injections in Children With Spinal Muscular Atrophy
- (2016) Manon Haché et al. JOURNAL OF CHILD NEUROLOGY
- Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
- (2016) Richard S Finkel et al. LANCET
- Decoding ALS: from genes to mechanism
- (2016) J. Paul Taylor et al. NATURE
- The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease
- (2016) Aaron R. Haeusler et al. NATURE REVIEWS NEUROSCIENCE
- Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy
- (2016) Claudia A. Chiriboga et al. NEUROLOGY
- C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD
- (2016) Yuanjing Liu et al. NEURON
- Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs
- (2016) Jie Jiang et al. NEURON
- Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
- (2016) Suzan M. Hammond et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Projected increase in amyotrophic lateral sclerosis from 2015 to 2040
- (2016) Karissa C. Arthur et al. Nature Communications
- Adeno-associated virus and lentivirus vectors: a refined toolkit for the central nervous system
- (2016) Daniel Blessing et al. Current Opinion in Virology
- Isoform-specific antibodies reveal distinct subcellular localizations of C9orf72 in amyotrophic lateral sclerosis
- (2015) Shangxi Xiao et al. ANNALS OF NEUROLOGY
- Genetic causes of amyotrophic lateral sclerosis: New genetic analysis methodologies entailing new opportunities and challenges
- (2015) Giuseppe Marangi et al. BRAIN RESEARCH
- Gene therapy for neurological disorders
- (2015) Chi-Jing Choong et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Gene and splicing therapies for neuromuscular diseases
- (2015) Aurelie Goyenvalle Frontiers in Bioscience-Landmark
- Multifactorial Gene Therapy Enhancing the Glutamate Uptake System and Reducing Oxidative Stress Delays Symptom Onset and Prolongs Survival in the SOD1-G93A ALS Mouse Model
- (2015) Chen Benkler et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Patterns of Weakness, Classification of Motor Neuron Disease, and Clinical Diagnosis of Sporadic Amyotrophic Lateral Sclerosis
- (2015) Jeffrey M. Statland et al. NEUROLOGIC CLINICS
- Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice
- (2015) Owen M. Peters et al. NEURON
- C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD
- (2015) Jacqueline G. O’Rourke et al. NEURON
- Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
- (2015) E. T. Cirulli et al. SCIENCE
- Systemic AAVrh10 provides higher transgene expression than AAV9 in the brain and the spinal cord of neonatal mice
- (2015) Yannick Tanguy et al. Frontiers in Molecular Neuroscience
- Therapeutic potentials of gene silencing by RNA interference: Principles, challenges, and new strategies
- (2014) Yan Deng et al. GENE
- C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking
- (2014) Manal A. Farg et al. HUMAN MOLECULAR GENETICS
- Rabies Virus Envelope Glycoprotein Targets Lentiviral Vectors to the Axonal Retrograde Pathway in Motor Neurons
- (2014) James N. Hislop et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nonsense-mediated decay as a terminating mechanism for antisense oligonucleotides
- (2014) Amanda J. Ward et al. NUCLEIC ACIDS RESEARCH
- Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients
- (2014) Koji Abe et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- AAV-Mediated Gene Therapy for Research and Therapeutic Purposes
- (2014) R. Jude Samulski et al. Annual Review of Virology
- Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis
- (2013) Hongyan Wang et al. HUMAN MOLECULAR GENETICS
- Enhanced Central Nervous System Transduction with Lentiviral Vectors Pseudotyped with RVG/HIV-1gp41 Chimeric Envelope Glycoproteins
- (2013) A. Trabalza et al. JOURNAL OF VIROLOGY
- An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study
- (2013) Timothy M Miller et al. LANCET NEUROLOGY
- Therapeutic AAV9-mediated Suppression of Mutant SOD1 Slows Disease Progression and Extends Survival in Models of Inherited ALS
- (2013) Kevin D Foust et al. MOLECULAR THERAPY
- Long-distance Axonal Transport of AAV9 Is Driven by Dynein and Kinesin-2 and Is Trafficked in a Highly Motile Rab7-positive Compartment
- (2013) Michael J Castle et al. MOLECULAR THERAPY
- State of play in amyotrophic lateral sclerosis genetics
- (2013) Alan E Renton et al. NATURE NEUROSCIENCE
- Axonal transport deficits and neurodegenerative diseases
- (2013) Stéphanie Millecamps et al. NATURE REVIEWS NEUROSCIENCE
- RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
- (2013) Christopher J. Donnelly et al. NEURON
- Glial Promoter Selectivity following AAV-Delivery to the Immature Brain
- (2013) Georg von Jonquieres et al. PLoS One
- Highly Efficient Retrograde Gene Transfer into Motor Neurons by a Lentiviral Vector Pseudotyped with Fusion Glycoprotein
- (2013) Miyabi Hirano et al. PLoS One
- Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration
- (2013) C. Lagier-Tourenne et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion
- (2013) D. Sareen et al. Science Translational Medicine
- The AAV Vector Toolkit: Poised at the Clinical Crossroads
- (2012) Aravind Asokan et al. MOLECULAR THERAPY
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse
- (2011) Paul N. Porensky et al. HUMAN MOLECULAR GENETICS
- Amyotrophic lateral sclerosis
- (2011) Matthew C Kiernan et al. LANCET
- Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis
- (2011) Laura Ferraiuolo et al. Nature Reviews Neurology
- P525L FUS mutation is consistently associated with a severe form of juvenile Amyotrophic Lateral Sclerosis
- (2011) Amelia Conte et al. NEUROMUSCULAR DISORDERS
- Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
- (2011) Mariely DeJesus-Hernandez et al. NEURON
- A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
- (2011) Alan E. Renton et al. NEURON
- Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy
- (2011) M. A. Passini et al. Science Translational Medicine
- RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
- (2010) C. Frank Bennett et al. Annual Review of Pharmacology and Toxicology
- Lentiviral Vectors in Gene Therapy: Their Current Status and Future Potential
- (2010) David Escors et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice
- (2010) Elisa Dominguez et al. HUMAN MOLECULAR GENETICS
- AAV4-mediated Expression of IGF-1 and VEGF Within Cellular Components of the Ventricular System Improves Survival Outcome in Familial ALS Mice
- (2010) James C Dodge et al. MOLECULAR THERAPY
- Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
- (2010) Kevin D Foust et al. NATURE BIOTECHNOLOGY
- Systemic Delivery of scAAV9 Expressing SMN Prolongs Survival in a Model of Spinal Muscular Atrophy
- (2010) C. F. Valori et al. Science Translational Medicine
- Lentiviral delivery of short hairpin RNAs
- (2009) N. Manjunath et al. ADVANCED DRUG DELIVERY REVIEWS
- Prognostic factors in ALS: A critical review
- (2009) Adriano Chiò et al. Amyotrophic Lateral Sclerosis
- AAV as a Gene Transfer Vector for the Treatment of Neurological Disorders: Novel Treatment Thoughts for ALS
- (2009) Mark Hester et al. CURRENT GENE THERAPY
- Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study
- (2009) A. Alonso et al. EUROPEAN JOURNAL OF NEUROLOGY
- Incidence of amyotrophic lateral sclerosis in Europe
- (2009) G. Logroscino et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS)
- (2009) Michael J. Strong JOURNAL OF THE NEUROLOGICAL SCIENCES
- Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons
- (2009) Sandra Duque et al. MOLECULAR THERAPY
- Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
- (2009) C. Vance et al. SCIENCE
- Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
- (2009) T. J. Kwiatkowski et al. SCIENCE
- Retrogradely transported siRNA silences human mutant SOD1 in spinal cord motor neurons
- (2009) Albert A. Rizvanov et al. EXPERIMENTAL BRAIN RESEARCH
- Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice
- (2008) Hidefumi Ito et al. EXPERIMENTAL NEUROLOGY
- Delivery of AAV-IGF-1 to the CNS Extends Survival in ALS Mice Through Modification of Aberrant Glial Cell Activity
- (2008) James C Dodge et al. MOLECULAR THERAPY
- Self-complementary AAV Vectors; Advances and Applications
- (2008) Douglas M McCarty MOLECULAR THERAPY
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
- (2008) Kevin D Foust et al. NATURE BIOTECHNOLOGY
- Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS
- (2008) Colin K. Franz et al. NEUROBIOLOGY OF DISEASE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started